Search
for
Sort by
Research 181–210 of 1000+
- Efficacy and safety of JAK inhibitors in treating lichen planopilaris or frontal fibrosing alopecia
- Role of Sodium–Glucose Cotransporter-2 Inhibitors in Managing Polycystic Ovary Syndrome: A Systematic Review
- Unraveling Ritlecitinib: an in-depth analysis of JAK3 inhibitor for the treatment of alopecia areata
- Infectious events in patients with alopecia areata treated with JAK inhibitors: low burden and minimal impact on persistence in treatment
- JAK-inhibitors in the therapy of comorbid diseases – atopic dermatitis and alopecia areata: literature review and experience of clinical practice
- The relative efficacy of monotherapy with Janus kinase inhibitors, dupilumab and apremilast in adults with alopecia areata: Network meta‐analyses of clinical trials
- Janus kinase inhibitors for alopecia areata: A narrative review
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- Perifolliculitis capitis abscedens et suffodiens treatment with tumor necrosis factor inhibitors and baricitinib: A case report and literature review
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- The Mechanisms of Anabolic Steroids, Selective Androgen Receptor Modulators and Myostatin Inhibitors
- Pharmacophore and Atom Based 3D QSAR Studies on the Novel 5-Alpha-Reductase Inhibitors
- 331 An open label clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- JAK Inhibitor Safety in Atopic Dermatitis and Alopecia Areata: A 4.5-Year Real-World Retrospective Cohort Study
- Alopecia areata: A clinical review of the changing landscape with Janus kinase inhibitors
- Adverse events associated with aromatase inhibitors: an analysis of real-world datasets and drug-gene interaction network
- A Review on the Use and Effectiveness of JAK Inhibitor in the Management of Lichen Planopilaris
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- Hidradenitis suppurativa secondary to treatment with a gamma secretase inhibitor
- Janus Kinase inhibitors in dermatology: a review
- Epidermal Growth Factor Receptor Inhibitor–Induced Symmetrical Drug-Related Intertriginous and Flexural Exanthema: Should You Discontinue the Offending Agent?
- Treatment of Alopecia Areata with Oral JAK Inhibitor : Focusing on Clinical Outcomes with Baricitinib
- Aromatase inhibitor–induced hair loss in two adolescents
- Comment on ‘Androgenetic alopecia is associated with increased scalp hardness’: role of phosphodiesterase inhibitors?
- Melanotic pigmentation in excisional scar of melanoma patient who received BRAF and MEK inhibitors
- 1072 Promotion of hair growth in normal mouse skin and alopecia areata by topical treatment of HDAC inhibitors
- Janus kinase inhibitors for the use of alopecia areata: A promising therapeutic of the future
- Mitigation of epidermal growth factor receptor inhibitor-induced side effects utilizing melanin and vascular-specific lasers: A case report series
- 075 Clinical investigation of JAK inhibitor Tofacitinib in scarring alopecias
- A New Era of 5α-Reductase Inhibitors for Androgenetic Alopecia